These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 18684188

  • 1. Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease.
    Schoepfer AM, Flogerzi B, Fallegger S, Schaffer T, Mueller S, Nicod L, Seibold F.
    Am J Gastroenterol; 2008 Nov; 103(11):2799-806. PubMed ID: 18684188
    [Abstract] [Full Text] [Related]

  • 2. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, Perich R, Sanchez-Torres A, Pastor C, Sanchez-Schwartz C, Medina M, Gamboa R, Ugarte M.
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [Abstract] [Full Text] [Related]

  • 3. [Evolution of IGRA researches].
    Ariga H, Harada N.
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [Abstract] [Full Text] [Related]

  • 4. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L, Rochat T, Martin PY, Saudan P, Janssens JP.
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [Abstract] [Full Text] [Related]

  • 5. Interferon-gamma release assay clarifies the effect of bacille Calmette-Guérin vaccination in Greek army recruits.
    Katsenos S, Nikolopoulou M, Konstantinidis AK, Gartzonika C, Gogali A, Margelis I, Tatsioni A, Mavridis A, Constantopoulos SH, Daskalopoulos G.
    Int J Tuberc Lung Dis; 2010 May; 14(5):545-50. PubMed ID: 20392346
    [Abstract] [Full Text] [Related]

  • 6. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
    Soborg B, Ruhwald M, Hetland ML, Jacobsen S, Andersen AB, Milman N, Thomsen VO, Jensen DV, Koch A, Wohlfahrt J, Ravn P.
    J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
    [Abstract] [Full Text] [Related]

  • 7. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
    Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, Reves RR, Toney SR, Daniels LJ, LoBue PA.
    Clin Infect Dis; 2007 Oct 01; 45(7):837-45. PubMed ID: 17806047
    [Abstract] [Full Text] [Related]

  • 8. Comparison of tuberculin skin test with a whole-blood interferon gamma assay and ELISA, in HIV positive children and adolescents with TB.
    Stavri H, Ene L, Popa GL, Duiculescu D, Murgoci G, Marica C, Ulea I, Cus G, Popa MI.
    Roum Arch Microbiol Immunol; 2009 Oct 01; 68(1):14-9. PubMed ID: 19507622
    [Abstract] [Full Text] [Related]

  • 9. Is the QuantiFERON-TB blood assay a good replacement for the tuberculin skin test in tuberculosis screening? a pilot study at Berkshire Medical Center.
    Zhao X, Mazlagic D, Flynn EA, Hernandez H, Abbott CL.
    Am J Clin Pathol; 2009 Nov 01; 132(5):678-86. PubMed ID: 19846807
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients.
    Andrisani G, Armuzzi A, Papa A, Marzo M, Felice C, Pugliese D, De Vitis I, Rapaccini GL, Guidi L.
    J Gastrointestin Liver Dis; 2013 Mar 01; 22(1):21-5. PubMed ID: 23539386
    [Abstract] [Full Text] [Related]

  • 11. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
    Oxlade O, Schwartzman K, Menzies D.
    Int J Tuberc Lung Dis; 2007 Jan 01; 11(1):16-26. PubMed ID: 17217125
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers.
    Lee SS, Liu YC, Huang TS, Chen YS, Tsai HC, Wann SR, Lin HH.
    Scand J Infect Dis; 2008 Jan 01; 40(5):373-80. PubMed ID: 18418798
    [Abstract] [Full Text] [Related]

  • 13. Disease activity is an important factor for indeterminate interferon-γ release assay results in children with inflammatory bowel disease.
    Hradsky O, Ohem J, Zarubova K, Mitrova K, Durilova M, Kotalova R, Nevoral J, Zemanova I, Dryak P, Bronsky J.
    J Pediatr Gastroenterol Nutr; 2014 Mar 01; 58(3):320-4. PubMed ID: 24126833
    [Abstract] [Full Text] [Related]

  • 14. Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.
    Papay P, Primas C, Eser A, Novacek G, Winkler S, Frantal S, Angelberger S, Mikulits A, Dejaco C, Kazemi-Shirazi L, Vogelsang H, Reinisch W.
    Aliment Pharmacol Ther; 2012 Nov 01; 36(9):858-65. PubMed ID: 22978645
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.
    Marra F, Marra CA, Sadatsafavi M, Morán-Mendoza O, Cook V, Elwood RK, Morshed M, Brunham RC, Fitzgerald JM.
    Int J Tuberc Lung Dis; 2008 Dec 01; 12(12):1414-24. PubMed ID: 19017451
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
    Deuffic-Burban S, Atsou K, Viget N, Melliez H, Bouvet E, Yazdanpanah Y.
    Int J Tuberc Lung Dis; 2010 Apr 01; 14(4):471-81. PubMed ID: 20202306
    [Abstract] [Full Text] [Related]

  • 17. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
    Winje BA, Oftung F, Korsvold GE, Mannsåker T, Ly IN, Harstad I, Dyrhol-Riise AM, Heldal E.
    BMC Infect Dis; 2008 Oct 17; 8():140. PubMed ID: 18928541
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment.
    Sauzullo I, Mengoni F, Scrivo R, Valesini G, Potenza C, Skroza N, Marocco R, Lichtner M, Vullo V, Mastroianni CM.
    Int J Tuberc Lung Dis; 2010 Jul 17; 14(7):834-40. PubMed ID: 20550765
    [Abstract] [Full Text] [Related]

  • 19. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
    Bergamini BM, Losi M, Vaienti F, D'Amico R, Meccugni B, Meacci M, De Giovanni D, Rumpianesi F, Fabbri LM, Balli F, Richeldi L.
    Pediatrics; 2009 Mar 17; 123(3):e419-24. PubMed ID: 19254978
    [Abstract] [Full Text] [Related]

  • 20. QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection.
    Manuel O, Kumar D.
    Expert Rev Mol Diagn; 2008 May 17; 8(3):247-56. PubMed ID: 18598104
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.